Första AP-fonden’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-64,700
| Closed | -$1.83M | – | 566 |
|
|
2025
Q1 | $1.83M | Sell |
64,700
-4,700
| -7% | -$133K | 0.01% | 541 |
|
|
2024
Q4 | $2.89M | Buy |
69,400
+500
| +0.7% | +$20.8K | 0.02% | 511 |
|
|
2024
Q3 | $4.6M | Buy |
68,900
+8,400
| +14% | +$561K | 0.04% | 414 |
|
|
2024
Q2 | $7.18M | Sell |
60,500
-6,100
| -9% | -$724K | 0.06% | 291 |
|
|
2024
Q1 | $7.1M | Buy |
66,600
+7,000
| +12% | +$746K | 0.06% | 311 |
|
|
2023
Q4 | $5.93M | Sell |
59,600
-3,100
| -5% | -$308K | 0.06% | 312 |
|
|
2023
Q3 | $6.48M | Buy |
62,700
+300
| +0.5% | +$31K | 0.07% | 278 |
|
|
2023
Q2 | $7.58M | Buy |
62,400
+300
| +0.5% | +$36.5K | 0.08% | 262 |
|
|
2023
Q1 | $9.54M | Sell |
62,100
-54,000
| -47% | -$8.29M | 0.11% | 199 |
|
|
2022
Q4 | $20.9M | Buy |
116,100
+24,600
| +27% | +$4.42M | 0.24% | 89 |
|
|
2022
Q3 | $10.8M | Buy |
91,500
+30,400
| +50% | +$3.59M | 0.13% | 161 |
|
|
2022
Q2 | $8.73M | Sell |
61,100
-21,800
| -26% | -$3.11M | 0.11% | 195 |
|
|
2022
Q1 | $14.3M | Buy |
82,900
+800
| +1% | +$138K | 0.16% | 131 |
|
|
2021
Q4 | $20.9M | Buy |
82,100
+5,100
| +7% | +$1.3M | 0.21% | 93 |
|
|
2021
Q3 | $29.6M | Buy |
77,000
+700
| +0.9% | +$269K | 0.34% | 60 |
|
|
2021
Q2 | $17.9M | Buy |
76,300
+21,300
| +39% | +$5.01M | 0.21% | 95 |
|
|
2021
Q1 | $7.2M | Buy |
55,000
+5,500
| +11% | +$720K | 0.1% | 235 |
|
|
2020
Q4 | $5.17M | Sell |
49,500
-4,900
| -9% | -$512K | 0.08% | 308 |
|
|
2020
Q3 | $3.85M | Buy |
54,400
+17,100
| +46% | +$1.21M | 0.08% | 286 |
|
|
2020
Q2 | $2.4M | Buy |
+37,300
| New | +$2.4M | 0.06% | 329 |
|